NEWS & VIEWS
Oxford Capital and our portfolio companies.
- All
- Blogs & Insights
- Oxford Capital News
- Portfolio Company News
- Videos
- All
- Blogs & Insights
- Oxford Capital News
- Portfolio Company News
- Videos
Backing Founders interview with James Kent, Co-Founder & CEO, Xihelm
Featuring Co-Founder and CEO James Kent
We’re moving! Our new office
We are delighted to announce that Oxford Capital is moving to new offices this month, after over 20 years in Cumnor Hill we are making the move into central Oxford at the heart of all the innovations within the Oxford technology cluster. This will also …
Oxford Capital wins VC Investor of the Year – GIANT Health Awards
We were thrilled to win VC Investor of the Year at this year’s GIANT Health Awards, in recognition of our work with digital health companies such as Push Doctor and HelloSelf.
Bower Collective – Meet the Founders
We recently invested into sustainable subscription company Bower Collective, alongside Founders Factory and a number of angel investors. Bower offers a range of home and personal care products and is on a mission to eliminate plastic waste. It has developed an innovative approach to ecommerce …
Artfinder highlights positive growth through the pandemic
Portfolio company, Artfinder highlights the recent growth of the business and its future plans in this interview.
‘A Christmas Carol’ trailer released – Media EIS portfolio
First look at the Christmas Carol trailer! A fantastic film selected by our media EIS partner, Quickfire Films.
Moneybox listed highly in Deloitte’s Technology Fast 50 list
Portfolio company, Moneybox has been listed as one of the fastest growing technology companies in the UK in this year’s Deloitte Fast 50 list.
Moneybox, Curve and ePorta named in Telegraph Tech 100 list for 2020
The Telegraph Tech 100 list celebrates the best and brightest in the UK’s start-ups scene and highlights that entrepreneurs in Britain have emerged stronger than ever through the pandemic crisis.
Oxford BioTherapeutics expands its partnership with Boehringer Ingelheim
Portfolio company, Oxford BioTherapeutics has expanded its partnership with Boehringer Ingelheim to do more to target difficult-to-reach cancers and deliver best in class treatment for cancer patients.
Portfolio company – Hometree secures £7m in latest fundraising round
Insurtech Hometree raises £7m following a surge in demand and new partnerships through COVID-19. The funding round led by global investment firm Anthemis, and existing investors DN Capital and Literacy Capital. Other participants included Gumtree Founder Michael Pennington, Oxford Capital, Jon Moulton and many of …
Oxford Capital recognised at BVCA Excellence in ESG 2020 awards
BVCA recognises Excellence in ESG 8 October 2020 The importance of ESG and responsible investment has never been more urgent for the private equity and venture capital industry. The COVID-19 pandemic has reinforced the need to place climate change, health and safety, and other important …
LinkedIn Top Startups 2020 – Moneybox named one of the top 10 UK companies to watch
Our portfolio company, Moneybox is named as one of the UK’s top 10 start ups for 2020, by LinkedIn. It has been rated for major milestones in 2020, including its £30m fundraising round and £7m crowdfunding campaign. In addition, it hit £1bn in assets under …
Future of work – 5 models for the start-up office of the future
Blog from Founder Partner, David Mott focuses on the future of work and how start ups will need to adapt to the new normal.
Post pandemic opportunities – the rise and rise of ecommerce
The world as we know it changed beyond all recognition when the UK went into lockdown on 23rd March. For the first time, in many of our lifetimes – we were forced to stay at home, limit contact with our nearest and dearest and find …
Oxford Capital rated in list of key UK venture capital firms
Recent figures from the KPMG Global Venture Pulse Survey shows that venture capital investment continues to maintain a robust stronghold in Q2 2020, with a UK investment of £2.6bn. Oxford Capital mentioned amongst a list of the top VC companies in the UK.
Oxford Capital exits investment in UltraSoc in sale to Siemens
We are delighted to announce that Cambridge-based portfolio company UltraSoc Technologies Ltd has been acquired by Siemens. This is our second profitable deep-tech exit in six months. UltraSoc provides technology analysing and developing the core hardware of systems-on-chip (SoC). This is the bedrock of …
